Moses Badio
Moses Badio
1Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia
1,#,
Edouard Lhomme
Edouard Lhomme
2Univ. Bordeaux, Inserm, Bordeaux Population Health Research, Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000 Bordeaux, France
2,#,
Mark Kieh
Mark Kieh
1Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia
1,
Abdoul Habib Beavogui
Abdoul Habib Beavogui
3Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Mafèrinyah, Guinea
3,
Stephen B Kennedy
Stephen B Kennedy
1Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia
1,
Seydou Doumbia
Seydou Doumbia
4University of Sciences, Technique and Technology of Bamako, Bamako, Mali
4,
Bailah Leigh
Bailah Leigh
5College of Medicine and Allied Health Sciences (COMAHS), University of Sierra Leone, Freetown, Sierra Leone
5,
Samba O Sow
Samba O Sow
6Centre pour le Développement des Vaccins, Bamako, Mali
6,
Alpha Diallo
Alpha Diallo
7INSERM, Pôle de Recherche Clinique, 75013 Paris, France
7,
Daniela Fusco
Daniela Fusco
7INSERM, Pôle de Recherche Clinique, 75013 Paris, France
7,
Matthew Kirchoff
Matthew Kirchoff
8National Institute of Allergy and Infectious Diseases, Bethesda, MD USA
8,
Monique Termote
Monique Termote
2Univ. Bordeaux, Inserm, Bordeaux Population Health Research, Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000 Bordeaux, France
2,
Renaud Vatrinet
Renaud Vatrinet
9REACTing, Institut Thématique Immunologie, Inflammation, Infectiologie et Microbiologie, Inserm, Paris, France
9,
Deborah Wentworth
Deborah Wentworth
10Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN USA
10,
Helène Esperou
Helène Esperou
7INSERM, Pôle de Recherche Clinique, 75013 Paris, France
7,
H Clifford Lane
H Clifford Lane
8National Institute of Allergy and Infectious Diseases, Bethesda, MD USA
8,
Jerome Pierson
Jerome Pierson
8National Institute of Allergy and Infectious Diseases, Bethesda, MD USA
8,
Deborah Watson-Jones
Deborah Watson-Jones
11London School of Hygiene & Tropical Medicine, London, UK
11,
Céline Roy
Céline Roy
2Univ. Bordeaux, Inserm, Bordeaux Population Health Research, Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000 Bordeaux, France
2,
Eric D’Ortenzio
Eric D’Ortenzio
9REACTing, Institut Thématique Immunologie, Inflammation, Infectiologie et Microbiologie, Inserm, Paris, France
12AP-HP, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales, F-75018 Paris, France
9,12,
Brian Greenwood
Brian Greenwood
11London School of Hygiene & Tropical Medicine, London, UK
11,
Genevieve Chêne
Genevieve Chêne
2Univ. Bordeaux, Inserm, Bordeaux Population Health Research, Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000 Bordeaux, France
2,
Laura Richer
Laura Richer
2Univ. Bordeaux, Inserm, Bordeaux Population Health Research, Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000 Bordeaux, France
2,
James D Neaton
James D Neaton
10Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN USA
10,
Yazdan Yazdanpanah
Yazdan Yazdanpanah
9REACTing, Institut Thématique Immunologie, Inflammation, Infectiologie et Microbiologie, Inserm, Paris, France
12AP-HP, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales, F-75018 Paris, France
9,12,✉;
the PREVAC study team
1Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia
2Univ. Bordeaux, Inserm, Bordeaux Population Health Research, Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000 Bordeaux, France
3Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Mafèrinyah, Guinea
4University of Sciences, Technique and Technology of Bamako, Bamako, Mali
5College of Medicine and Allied Health Sciences (COMAHS), University of Sierra Leone, Freetown, Sierra Leone
6Centre pour le Développement des Vaccins, Bamako, Mali
7INSERM, Pôle de Recherche Clinique, 75013 Paris, France
8National Institute of Allergy and Infectious Diseases, Bethesda, MD USA
9REACTing, Institut Thématique Immunologie, Inflammation, Infectiologie et Microbiologie, Inserm, Paris, France
10Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN USA
11London School of Hygiene & Tropical Medicine, London, UK
12AP-HP, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales, F-75018 Paris, France
© The Author(s) 2021
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
